The pairing. Both repair pathways together, when recovery is the bottleneck.
This peptide combination is studied for its potential synergistic activity across complementary biological pathways. TB-500's interaction with actin polymerization and cytoskeletal organization may support cell migration and structural repair, while BPC-157's engagement of VEGF and nitric oxide pathways is associated with angiogenic and tissue remodeling processes. Research suggests this combination may support fibroblast activity and connective tissue homeostasis. Intended for research purposes.


This combination pairs two of the most-studied recovery peptides in one vial. TB-500’s engagement of actin polymerization supports cell migration and structural repair, while BPC-157’s activity on VEGF and nitric oxide pathways is associated with angiogenesis and tissue remodeling — two complementary mechanisms researchers point to for broader recovery coverage than either peptide alone.
Research Use Only. These products have not been evaluated or approved by the FDA for use as drugs, therapeutics, diagnostics, or dietary supplements, and are not intended for administration to humans or animals. No product description or mechanism-of-action information constitutes a health claim or therapeutic endorsement. Any clinical use is at the sole discretion of a licensed healthcare provider in compliance with applicable laws. Individual results may vary.